Search for:
Category

Singapore

Category

The Ministry of Health (MOH) is conducting a public consultation from 11 December 2023 to 11 January 2024 on the proposed Health Information Bill (HIB). Through the HIB, the MOH intends to establish a framework governing the safe collection, use and sharing of health information across Singapore’s healthcare ecosystem to facilitate better continuity and seamless transition of care.

On 18 October 2023, the Monetary Authority of Singapore (MAS) issued a set of consultation papers proposing guidelines on transition planning by banks, insurers and asset managers (“TP Guidelines”) to enable the global transition to a net-zero economy. The TP Guidelines set out MAS’ supervisory expectations for the in-scope financial institutions to have a sound transition-planning process to enable their customers and investee companies to take effective climate change mitigation and adaptation measures when dealing with the global transition to a net-zero economy and the expected physical effects of climate change.

In October 2023, the Health Sciences Authority (HSA) participated in a one-week INTERPOL-led, internet-based operation involving 89 member countries targeting the sale of illegal health products.
The HSA announced that it removed over 4,600 listings of illegal health products from local e-commerce and social media platforms and seized more than 60,000 units of illegal health products at the Singapore Customs during a week of intensified surveillance from 3 to 10 October 2023.

The Monetary Singapore Authority of Singapore (MAS) and Infocomm Media Authority (IMDA) published a joint consultation paper, which sets out a Shared Responsibility Framework (SRF) allocating losses arising from scams among financial institutions (FIs), telecommunication operators (telcos) and consumers.
Under the proposed SRF, FIs and telcos will have to fulfill their respective anti-scam duties. Failure to do so may result in the FIs and telcos making payouts to scam victims for certain types of phishing scams.

On 20 October 2023, the Cyber Security Agency of Singapore, in collaboration with the Ministry of Health, Health Sciences Authority and national health technology agency, Synapxe, launched the Cybersecurity Labelling Scheme for Medical Devices sandbox. Medical device manufacturers are invited to participate in the sandbox to gain a first-mover advantage in enhancing the security of their products.

On 29 September 2023, the Health Sciences Authority rolled out a one-year transition plan for companies to fully comply with the requirement for chemical drug substance manufacturers to provide Evidence of Good Manufacturing Practice Compliance. The HSA also provided clarity over the types of evidence that companies can submit as proof of GMP compliance.